Cargando…

Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia

BACKGROUND: Congenital pseudoarthrosis of the tibia (CPT) is one of the most difficult conditions to treat. METHODS: Five girls and 3 boys with CPT were treated by vascularized fibular grafting (VFG). The average age at VFG was 7.0 years (range: 1.9–11.5 years) with an average follow-up term of 11.7...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Akio, Yoshida, Tatsuya, Uchida, Yoshio, Kojima, Tetsuo, Kubota, Hideaki, Iwamoto, Yukihide
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278130/
https://www.ncbi.nlm.nih.gov/pubmed/18325091
http://dx.doi.org/10.1186/1749-799X-3-13
_version_ 1782152041236267008
author Sakamoto, Akio
Yoshida, Tatsuya
Uchida, Yoshio
Kojima, Tetsuo
Kubota, Hideaki
Iwamoto, Yukihide
author_facet Sakamoto, Akio
Yoshida, Tatsuya
Uchida, Yoshio
Kojima, Tetsuo
Kubota, Hideaki
Iwamoto, Yukihide
author_sort Sakamoto, Akio
collection PubMed
description BACKGROUND: Congenital pseudoarthrosis of the tibia (CPT) is one of the most difficult conditions to treat. METHODS: Five girls and 3 boys with CPT were treated by vascularized fibular grafting (VFG). The average age at VFG was 7.0 years (range: 1.9–11.5 years) with an average follow-up term of 11.7 years (range: 4.9–19.6 years). Five of the children had undergone multiple operations before VFG, while the other 3 had no such history. RESULTS: Bone consolidation was obtained in all cases after an average term of 6.6 months (range: 4–10 months); this was with the first VFG in 7 cases but with the second VFG in 1 case. Complication of stress fracture and ankle pain occurred in 1 and 3 cases, respectively, only in cases undergoing multiple operations. Leg-length discrepancy was more prominent in the patients with multiple previous operations (mean: 7.5 cm), than in the cases with no prior surgery (mean: 0.7 cm). CONCLUSION: The long-term results of VFG for CPT were excellent, especially in the cases, with no prior surgery. VFG should be considered as a primary treatment option for CPT.
format Text
id pubmed-2278130
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22781302008-04-02 Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia Sakamoto, Akio Yoshida, Tatsuya Uchida, Yoshio Kojima, Tetsuo Kubota, Hideaki Iwamoto, Yukihide J Orthop Surg Research Article BACKGROUND: Congenital pseudoarthrosis of the tibia (CPT) is one of the most difficult conditions to treat. METHODS: Five girls and 3 boys with CPT were treated by vascularized fibular grafting (VFG). The average age at VFG was 7.0 years (range: 1.9–11.5 years) with an average follow-up term of 11.7 years (range: 4.9–19.6 years). Five of the children had undergone multiple operations before VFG, while the other 3 had no such history. RESULTS: Bone consolidation was obtained in all cases after an average term of 6.6 months (range: 4–10 months); this was with the first VFG in 7 cases but with the second VFG in 1 case. Complication of stress fracture and ankle pain occurred in 1 and 3 cases, respectively, only in cases undergoing multiple operations. Leg-length discrepancy was more prominent in the patients with multiple previous operations (mean: 7.5 cm), than in the cases with no prior surgery (mean: 0.7 cm). CONCLUSION: The long-term results of VFG for CPT were excellent, especially in the cases, with no prior surgery. VFG should be considered as a primary treatment option for CPT. BioMed Central 2008-03-06 /pmc/articles/PMC2278130/ /pubmed/18325091 http://dx.doi.org/10.1186/1749-799X-3-13 Text en Copyright © 2008 Sakamoto et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sakamoto, Akio
Yoshida, Tatsuya
Uchida, Yoshio
Kojima, Tetsuo
Kubota, Hideaki
Iwamoto, Yukihide
Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia
title Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia
title_full Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia
title_fullStr Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia
title_full_unstemmed Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia
title_short Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia
title_sort long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278130/
https://www.ncbi.nlm.nih.gov/pubmed/18325091
http://dx.doi.org/10.1186/1749-799X-3-13
work_keys_str_mv AT sakamotoakio longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia
AT yoshidatatsuya longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia
AT uchidayoshio longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia
AT kojimatetsuo longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia
AT kubotahideaki longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia
AT iwamotoyukihide longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia